glp-1 egfr cut off CKJ REVIEW receptor agonists in patients with chronic kidney disease and either overweight or obesit View of Managing hyperglycaemia in

Noom GLP-1Rx Program involves a healthy diet, exercise, support, and additional features depending on program selection

Starting at lower doses and increasing more slowly often produces better long-term compliance with fewer side effects

Some patients experience significant nausea, vomiting, or diarrhoea during the initial weeks, which may necessitate slower dose increases or temporary dose reductions

Every protocol begins with a lower dose and increases gradually over weeks to months

The interaction between GLP-1s and birth control is unclear One key problem is that the process by which GLP-1s reduce the effectiveness of birth control isnt well understood

What Regulators Say After extensive review, regulatory agencies have concluded: No confirmed causal link between GLP-1 medications and anger or aggression No black box warnings related to mood Continued monitoring is appropriate This reflects a balanced interpretation of available evidencenot dismissal of patient experiences, but also not overstating risk